一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Signal Transduction and Targeted Therapy >>article
Signal Transduction and Targeted Therapy

Signal Transduction and Targeted Therapy

IF: 40.8
Download PDF

PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma

Published:21 May 2025 DOI: 10.1038/s41392-025-02250-7
Binfeng Liu,Wei Li,Wenchao Zhang,Chengyao Feng,Lu Wan,Shasha He,Ruiling Xu,Zheng Fu,Zhongyue Liu,Haodong Xu,Xin Jin,Chao Tu,Zhihong Li

Abstract

Cisplatin (DDP) remains a cornerstone therapy for osteosarcoma (OS); however, pervasive resistance severely limits its clinical efficacy and worsens patient outcomes. Developing strategies to enhance the chemotherapeutic responsiveness of OS cells is therefore of critical importance. Here, we conducted a kinome-wide clustered regularly interspaced short palindromic repeats (CRISPR) screen, coupled with transcriptome sequencing, to identify regulators of DDP sensitivity. This approach revealed protein kinase membrane-associated tyrosine/threonine 1 (PKMYT1) as a key regulator of DDP sensitivity in OS. Subsequent analysis of patient-derived clinical specimens, along with in vitro functional assays, demonstrated that DDP treatment induces the activation of PKMYT1 in OS cells. Importantly, PKMYT1 silencing markedly enhances cellular sensitivity to DDP, indicating its role in promoting chemoresistance. Mechanistically, PKMYT1 induces phosphorylation of nucleophosmin 1 (NPM1) at the S260 site, which competitively impairs NPM1 SUMOylation. This modification interferes with the recruitment of essential DNA damage response factors, including breast cancer suppressor gene 1 (BRCA1), receptor-associated protein 80 (RAP80), and RADiation sensitive protein 51 (RAD51), ultimately affecting double-strand break (DSB) repair. Furthermore, the selective PKMYT1 inhibitor RP6306 was found to synergize with DDP, amplifying its cytotoxic effects in OS cells. Collectively, these findings highlight PKMYT1 as a promising therapeutic target and provide a rationale for combinatorial strategies to overcome DDP resistance in OS.

Similar articles

IF:4.2

Cisplatin in cancer therapy: Molecular mechanisms of action

European journal of pharmacology Shaloam Dasari, Paul Bernard Tchounwou,etc Published: 5 October 2014
IF:3.7

Advances in Toxicological Research of the Anticancer Drug Cisplatin

Chemical Research in Toxicology Luyu Qi, Qun Luo,etc Published: 29 July 2019
IF:0

The role of thymidine kinase in cancer diseases.

Expert opinion on medical diagnostics Ondrej Topolcan, Lubos Holubec,etc Published: 1 February 2008
饶阳县| 云南省| 噶尔县| 元氏县| 乳山市| 天祝| 墨竹工卡县| 桂东县| 桦川县| 彰武县| 东乡族自治县| 赣榆县| 静宁县| 太仓市| 彭阳县| 新乐市| 龙井市| 百色市| 甘洛县| 乌苏市| 清原| 连江县| 永定县| 乐业县| 秭归县| 南木林县| 永登县| 仲巴县| 临澧县| 含山县| 禄劝| 岑溪市| 南昌县| 阜新| 日照市| 铜山县| 小金县| 阿荣旗| 桃源县| 陕西省| 阜城县|